spacer
home > ict > summer 2018 > patient privacy
PUBLICATIONS
International Clinical Trials

Patient Privacy

ICT: What is clinical trial transparency?

TrialScope: Clinical trial transparency can mean different things to different people. In its broadest sense, it is to make a wide range of information about a clinical trial available to the public. This includes registering the trial at the time that it begins enrolling participants, disclosing summary results of the trial once it completes, sharing the more detailed study report and anonymised patient data, and providing a plain-language summary of the trial results. All of these components have legal or regulatory requirements, but organisations are pressured to share more than what is legally mandated.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thomas Wicks, Chief Strategy Officer at TrialScope, has more than 17 years of experience with performance and content management solutions, specialising in applications for life sciences such as clinical trial disclosure, structured product labelling, and submissions management. Thomas has been on the PharmaCM team since 2007. Prior to the acquisition of PharmaCM by TrialScope, he served as the General Manager of PharmaCM at Deloitte and as the Director of PharmaCM Product Management at Intrasphere Technologies. Before joining Intrasphere, Thomas worked in leadership, client-facing positions for Revelwood and Shepherd Systems, focussed on performance management solutions.

Francine Lane is the Vice President of Global Transparency at TrialScope. In this role, she is responsible for helping TrialScope customers meet and exceed current disclosure expectations globally, giving them the tools they need to meet all the requirements in this evolving industry. Francine also dedicates her time to building relationships with external stakeholders, including sponsors, investigators, regulators, and transparency and patient advocates, to help align the goals and expectations of these groups, as well as help identify more consistent ways sponsors can meet industry standards. Prior to her role as Vice President of Global Transparency, Francine served as Director of Product Management at TrialScope.
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Appointment of Lisa Spence as Director of Clinical Supply Chain International Region

Philadelphia, PA – March 12, 2019. Leading biopharmaceutical services provider PCI Clinical Services (PCI) is pleased to announce the appointment of Lisa Spence as Director of Clinical Supply Chain – International Region.
More info >>

White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

NanoSight

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement